Increased expression of the cAMP-response element-binding protein (CBP)/β-catenin/FOXM1 transcriptional complex in TNBC cells in vivo was associated with a high proportion of cancer stem cells, high rates of drug resistance and poor survival outcome [16]. The gene discussed is FOXM1; the disease is cancer.